1318. Pharmacokinetics and Safety of Cefepime-Taniborbactam (formerly Cefepime/VNRX-5133) in Subjects with Renal Impairment

BACKGROUND: Taniborbactam is a novel, non-ß-lactam, ß-lactamase inhibitor with activity against serine (Class A, C, D) and metallo (Class B) ß-lactamases including epidemiologically important carbapenemases. Both cefepime and taniborbactam are predominantly renally excreted and are likely to require...

詳細記述

保存先:
書誌詳細
出版年:Open Forum Infect Dis
主要な著者: Geibel, Brooke, Dowell, James A, Marbury, Thomas C, Smith, William, McGovern, Paul C, Richards, Cynthia, Henkel, Tim
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2020
主題:
Poster Abstracts
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7777653/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa439.1500
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料